Literature DB >> 19626024

A 5' promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression.

K K Nicodemus, A J Law, A Luna, R Vakkalanka, R E Straub, J E Kleinman, D R Weinberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19626024      PMCID： PMC3271936          DOI： 10.1038/mp.2008.150

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  11 in total

1.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population.

Authors:  Hreinn Stefansson; Jane Sarginson; Augustine Kong; Phil Yates; Valgerdur Steinthorsdottir; Einar Gudfinnsson; Steinunn Gunnarsdottir; Nicholas Walker; Hannes Petursson; Caroline Crombie; Andres Ingason; Jeffrey R Gulcher; Kari Stefansson; David St Clair
Journal:  Am J Hum Genet       Date:  2002-12-11       Impact factor: 11.025

2.  Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.

Authors:  Chang-Gyu Hahn; Hoau-Yan Wang; Dan-Sung Cho; Konrad Talbot; Raquel E Gur; Wade H Berrettini; Kalindi Bakshi; Joshua Kamins; Karin E Borgmann-Winter; Steven J Siegel; Robert J Gallop; Steven E Arnold
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

3.  Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease.

Authors:  Amanda J Law; Barbara K Lipska; Cynthia Shannon Weickert; Thomas M Hyde; Richard E Straub; Ryota Hashimoto; Paul J Harrison; Joel E Kleinman; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

4.  Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins.

Authors:  S W Flynn; D J Lang; A L Mackay; V Goghari; I M Vavasour; K P Whittall; G N Smith; V Arango; J J Mann; A J Dwork; P Falkai; W G Honer
Journal:  Mol Psychiatry       Date:  2003-09       Impact factor: 15.992

5.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

6.  Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.

Authors:  Kristine Roy; Joshua C Murtie; Bassem F El-Khodor; Nicole Edgar; S Pablo Sardi; Bryan M Hooks; Marianne Benoit-Marand; Chinfei Chen; Holly Moore; Patricio O'Donnell; Daniela Brunner; Gabriel Corfas
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

7.  Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia.

Authors:  Lyudmila Georgieva; Albena Dimitrova; Dobril Ivanov; Ivan Nikolov; Nigel M Williams; Detelina Grozeva; Irina Zaharieva; Draga Toncheva; Michael J Owen; George Kirov; Michael C O'Donovan
Journal:  Biol Psychiatry       Date:  2008-05-07       Impact factor: 13.382

8.  Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain.

Authors:  A J Law; C Shannon Weickert; T M Hyde; J E Kleinman; P J Harrison
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms.

Authors:  Jeremy Hall; Heather C Whalley; Dominic E Job; Ben J Baig; Andrew M McIntosh; Kathryn L Evans; Pippa A Thomson; David J Porteous; David G Cunningham-Owens; Eve C Johnstone; Stephen M Lawrie
Journal:  Nat Neurosci       Date:  2006-10-29       Impact factor: 24.884

10.  Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia.

Authors:  Wei Tan; Yanhong Wang; Bert Gold; Jingshan Chen; Michael Dean; Paul J Harrison; Daniel R Weinberger; Amanda J Law
Journal:  J Biol Chem       Date:  2007-06-12       Impact factor: 5.157
View more
  21 in total

1.  Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice.

Authors:  Malcolm W Nason; Avishek Adhikari; Marjan Bozinoski; Joshua A Gordon; Lorna W Role
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism.

Authors:  M Shibuya; E Komi; R Wang; T Kato; Y Watanabe; M Sakai; M Ozaki; T Someya; H Nawa
Journal:  J Neural Transm (Vienna)       Date:  2010-06-05       Impact factor: 3.575

3.  Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Authors:  Graham M Pitcher; Lorraine V Kalia; David Ng; Nathalie M Goodfellow; Kathleen T Yee; Evelyn K Lambe; Michael W Salter
Journal:  Nat Med       Date:  2011-03-27       Impact factor: 53.440

Review 4.  Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.

Authors:  M Kvajo; H McKellar; J A Gogos
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

5.  Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk.

Authors:  Mark Z Kos; Melanie A Carless; Juan Peralta; August Blackburn; Marcio Almeida; David Roalf; Michael F Pogue-Geile; Konasale Prasad; Ruben C Gur; Vishwajit Nimgaonkar; Joanne E Curran; Ravi Duggirala; David C Glahn; John Blangero; Raquel E Gur; Laura Almasy
Journal:  Schizophr Bull       Date:  2015-09-24       Impact factor: 9.306

Review 6.  Neuregulin 3 and its roles in schizophrenia risk and presentation.

Authors:  Dimitrios Avramopoulos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-29       Impact factor: 3.568

Review 7.  Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.

Authors:  Darrick T Balu; Joseph T Coyle
Journal:  Neurosci Biobehav Rev       Date:  2010-10-15       Impact factor: 8.989

Review 8.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

9.  Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.

Authors:  Francesco Papaleo; Feng Yang; Clare Paterson; Sara Palumbo; Gregory V Carr; Yanhong Wang; Kirsten Floyd; Wenwei Huang; Craig J Thomas; Jingshan Chen; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

10.  Temporal Dynamics of the Neuregulin-ErbB Network in the Murine Prefrontal Cortex across the Lifespan.

Authors:  Clare Paterson; Brooke Cumming; Amanda J Law
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.